Stockreport

Immuneering to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference

Immuneering Corporation - Class A  (IMRX) 
PDF CAMBRIDGE, Mass., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop and commercialize univ [Read more]